Brief: Crescent Biopharma Appoints Jan Pinkas, Ph.D., As Chief Scientific Officer
08/07/2025 12:40
July 8 (Reuters) - Crescent Biopharma Inc (Pre-Reincorporation) CBIO.O: CRESCENT BIOPHARMA APPOINTS JAN PINKAS, PH.D., AS CHIEF SCIENTIFIC OFFICER Source text: ID:nGNX1RDCqT Further company coverage: CBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering